Mulders PF - Search Results

1

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

van Gils MP, Stenman UH, Schalken JA, Schröder FH, Luider TM, Lilja H, Bjartell A, Hamdy FC, Pettersson KS, Bischoff R, Takalo H, Nilsson O, Mulders PF, Bangma CH. van Gils MP, et al. Among authors: mulders pf. Eur Urol. 2005 Dec;48(6):1031-41. doi: 10.1016/j.eururo.2005.06.009. Epub 2005 Jul 1. Eur Urol. 2005. PMID: 16054748 Review.

2

Value of biochemical markers in the management of disseminated prostatic cancer.

Mulders PF, Fernandez del Moral P, Theeuwes AG, Oosterhof GO, van Berkel HT, Debruyne FM. Mulders PF, et al. Eur Urol. 1992;21(1):2-5. doi: 10.1159/000474790. Eur Urol. 1992. PMID: 1376692

3

Tumor heterogeneity as prognostic factor in patients with low-stage (T1-3N0M0) renal-cell carcinoma.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: mulders pf. Investig Urol (Berl). 1994;5:60-5. Investig Urol (Berl). 1994. PMID: 7719322 No abstract available.

4

Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinoma.

van der Poel HG, Mulders PF, Aalders TW, Oosterhof GO, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: mulders pf. Anal Cell Pathol. 1994 Aug;7(2):153-70. Anal Cell Pathol. 1994. PMID: 7993825

5

Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: mulders pf. Cancer. 1993 Nov 1;72(9):2667-74. doi: 10.1002/1097-0142(19931101)72:9<2667::aid-cncr2820720924>3.0.co;2-0. Cancer. 1993. PMID: 8402488

6

Treatment of advanced prostate cancer: the vaccine approach.

Mulders PF. Mulders PF. Scand J Urol Nephrol Suppl. 1999;203:41-3. doi: 10.1080/00365599950510049. Scand J Urol Nephrol Suppl. 1999. PMID: 10636569 No abstract available.

7

Immunotherapy for renal cell carcinoma.

Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Bleumer I, et al. Among authors: mulders pf. Eur Urol. 2003 Jul;44(1):65-75. doi: 10.1016/s0302-2838(03)00191-x. Eur Urol. 2003. PMID: 12814677 Review.

8

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.

Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. Han KR, et al. Among authors: mulders pf. J Urol. 2003 Dec;170(6 Pt 1):2221-4. doi: 10.1097/01.ju.0000096049.64863.a1. J Urol. 2003. PMID: 14634383

9

[The practice guideline 'Lower urinary-tract symptoms in middle-aged and elderly men' (second revision) from the Dutch College of General Practitioners; a response from the perspective of urology].

van Gils MP, Mulders PF. van Gils MP, et al. Among authors: mulders pf. Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1551-2. Ned Tijdschr Geneeskd. 2005. PMID: 16038156 Dutch.

10

Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.

Karakiewicz PI, Trinh QD, Bhojani N, Bensalah K, Salomon L, de la Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Schips L, Zigeuner R, Mulders PF, Valeri A, Descotes JL, Mejean A, Patard JJ. Karakiewicz PI, et al. Among authors: mulders pf. Eur Urol. 2007 Jun;51(6):1616-24. doi: 10.1016/j.eururo.2006.12.015. Epub 2006 Dec 14. Eur Urol. 2007. PMID: 17207909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters